{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:09:32Z","timestamp":1783958972328,"version":"3.55.0"},"reference-count":40,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK092232"],"award-info":[{"award-number":["R01-DK092232"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK122767"],"award-info":[{"award-number":["R01-DK122767"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK124138"],"award-info":[{"award-number":["R01-DK124138"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK132869"],"award-info":[{"award-number":["R01-DK132869"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK132875"],"award-info":[{"award-number":["R01-DK132875"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Patients receiving dialysis who have diabetes have a high burden of dysglycemia. Whereas traditional glycemic markers have limited accuracy and convenience in dialysis, continuous glucose monitoring (CGM) provides automated, less invasive, and more comprehensive glycemic data than do conventional measures. However, it remains unclear whether CGM is associated with improved clinical outcomes in patients undergoing dialysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>We examined the association between CGM use versus non-CGM use and survival among U.S. veterans receiving dialysis who also have diabetes, using linked national Veterans Affairs, U.S. Renal Data System, and Medicare data. We examined data from veterans undergoing dialysis and with diabetes with incident CGM use (newly prescribed CGM) versus non-CGM use over the period January 2012 to December 2023 matched by propensity score (PS) to address confounding by indication and who were followed for all-cause mortality events through February 2025. Associations of CGM use versus non-CGM use with death were evaluated using complete case analysis and multiple imputation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Among 2,008 patients in the complete case analysis cohort, CGM use was associated with a lower mortality risk in PS-matched unadjusted and doubly adjusted Cox models (reference: non-CGM use; hazard ratio [HR] 0.86 [95% CI 0.76, 0.98]; and 0.83 [95% CI 0.75, 0.92], respectively). Among 3,088 patients in the multiple imputation cohort, CGM use was also associated with greater survival in PS-matched unadjusted and doubly adjusted Cox models (HR 0.88 [95% CI 0.77, 0.99]; and 0.84 [95% CI 0.73, 0.96], respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>In veterans receiving dialysis who also had diabetes, incident CGM use was associated with better survival versus non-CGM use. Further studies are needed to determine underlying mechanisms and the impact of CGM on other dialysis outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title\/>\n                  <\/jats:sec>","DOI":"10.2337\/dc26-0004","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:05:07Z","timestamp":1780333507000},"page":"1285-1293","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["Continuous Glucose Monitoring and Mortality Risk Among U.S. Veterans Receiving Dialysis With Diabetes"],"prefix":"10.2337","volume":"49","author":[{"given":"Yoko","family":"Narasaki","sequence":"first","affiliation":[{"name":"David Geffen School of Medicine at University of California, Los Angeles (UCLA) 1 , Los Angeles, CA"},{"name":"Veterans Affairs Greater Los Angeles Healthcare System 2 , Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8666-0725","authenticated-orcid":false,"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at University of California, Los Angeles (UCLA) 1 , Los Angeles, CA"},{"name":"Veterans Affairs Greater Los Angeles Healthcare System 2 , Los Angeles, CA"},{"name":"The Lundquist Institute at Harbor-UCLA 3 , Torrance, CA"},{"name":"Tibor Rubin Veterans Affairs Long Beach Medical Center 4 , Long Beach, CA"},{"name":"University of California Irvine School of Medicine 5 , Orange, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaara","family":"Zisman-Ilani","sequence":"additional","affiliation":[{"name":"Barnett College of Public Health, Temple University 6 , Philadelphia, PA"},{"name":"Lewis Katz School of Medicine, Temple University 7 , Philadelphia, PA"},{"name":"University College London 8 , London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0624-698X","authenticated-orcid":false,"given":"David C.","family":"Klonoff","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, Mills-Peninsula Medical Center (Sutter Health) 9 , San Mateo, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba P.","family":"Kovesdy","sequence":"additional","affiliation":[{"name":"University of Tennessee Health Science Center 10 , Memphis, TN"},{"name":"Memphis Veterans Affairs Medical Center 11 , Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoping","family":"Li","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at University of California, Los Angeles (UCLA) 1 , Los Angeles, CA"},{"name":"Veterans Affairs Greater Los Angeles Healthcare System 2 , Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jin","sequence":"additional","affiliation":[{"name":"Tibor Rubin Veterans Affairs Long Beach Medical Center 4 , Long Beach, CA"},{"name":"University of California Irvine School of Medicine 5 , Orange, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Crowley","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine 12 , New Haven, CT"},{"name":"VA Connecticut Healthcare System 13 , West Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"M. Belcher","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine 12 , New Haven, CT"},{"name":"VA Connecticut Healthcare System 13 , West Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Gee","sequence":"additional","affiliation":[{"name":"iAdvocate, Inc. 14 , Richmond, VA"},{"name":"Sitter and Barfoot VA Medical Center 15 , Richmond, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg E.","family":"Gin","sequence":"additional","affiliation":[{"name":"Tibor Rubin Veterans Affairs Long Beach Medical Center 4 , Long Beach, CA"},{"name":"University of California Irvine School of Medicine 5 , Orange, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jordan","sequence":"additional","affiliation":[{"name":"Tibor Rubin Veterans Affairs Long Beach Medical Center 4 , Long Beach, CA"},{"name":"University of California Irvine School of Medicine 5 , Orange, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"You","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at University of California, Los Angeles (UCLA) 1 , Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C.","family":"Daza","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at University of California, Los Angeles (UCLA) 1 , Los Angeles, CA"},{"name":"Veterans Affairs Greater Los Angeles Healthcare System 2 , Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy","family":"Hanna","sequence":"additional","affiliation":[{"name":"University of California Irvine School of Medicine 5 , Orange, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danh V.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Veterans Affairs Greater Los Angeles Healthcare System 2 , Los Angeles, CA"},{"name":"University of California Irvine School of Medicine 5 , Orange, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9703-6469","authenticated-orcid":false,"given":"Connie M.","family":"Rhee","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at University of California, Los Angeles (UCLA) 1 , Los Angeles, CA"},{"name":"Veterans Affairs Greater Los Angeles Healthcare System 2 , Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"2026071311511106500_B1","unstructured":"U.S. Renal Data System\n          . 2024 USRDS Annual Data Report: epidemiology of kidney disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2024"},{"key":"2026071311511106500_B2","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2215\/CJN.0000000744","article-title":"The cardiovascular-kidney-metabolic health framework: implications for nephrology","volume":"20","author":"Rangaswami","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026071311511106500_B3","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2215\/CJN.0000000750","article-title":"GLP-1 receptor agonist outcomes, safety, and body mass index change in a national cohort of patients on dialysis","volume":"20","author":"Orandi","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026071311511106500_B4","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2337\/dc17-0110","article-title":"Association of glycemic status during progression of chronic kidney disease with early dialysis mortality in patients with diabetes","volume":"40","author":"Rhee","year":"2017","journal-title":"Diabetes Care"},{"key":"2026071311511106500_B5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.jrn.2018.07.003","article-title":"Glycemic status and mortality in chronic kidney disease according to transition versus nontransition to dialysis","volume":"29","author":"Rhee","year":"2019","journal-title":"J Ren Nutr"},{"key":"2026071311511106500_B6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/j.ajkd.2018.04.022","article-title":"Hypoglycemia-related hospitalizations and mortality among patients with diabetes transitioning to dialysis","volume":"72","author":"Rhee","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2026071311511106500_B7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MNH.0000000000000756","article-title":"Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease","volume":"31","author":"Rhee","year":"2022","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2026071311511106500_B8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrneph.2015.38","article-title":"Haemodialysis-induced hypoglycaemia and glycaemic disarrays","volume":"11","author":"Abe","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"2026071311511106500_B9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000511614","article-title":"The use of HbA1c, glycated albumin and continuous glucose monitoring to assess glucose control in the chronic kidney disease population including dialysis","volume":"145","author":"Bomholt","year":"2021","journal-title":"Nephron"},{"key":"2026071311511106500_B10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/sdi.13009","article-title":"Continuous glucose monitoring in an end-stage renal disease patient with diabetes receiving hemodialysis","volume":"34","author":"Narasaki","year":"2021","journal-title":"Semin Dial"},{"key":"2026071311511106500_B11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/19322968241292041","article-title":"Consensus report on the use of continuous glucose monitoring in chronic kidney disease and diabetes","volume":"19","author":"Rhee","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"2026071311511106500_B12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1932296814567227","article-title":"Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes","volume":"9","author":"Danese","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"2026071311511106500_B13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MNH.0000000000001106","article-title":"Continuous glucose monitoring and automated insulin delivery systems in the management of diabetes among individuals with chronic kidney disease on dialysis","volume":"34","author":"Liarakos","year":"2025","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2026071311511106500_B14","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.2337\/dc24-0635","article-title":"Accuracy of continuous glucose monitoring in hemodialysis patients with diabetes","volume":"47","author":"Narasaki","year":"2024","journal-title":"Diabetes Care"},{"key":"2026071311511106500_B15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/dia.2023.0013","article-title":"The Accuracy of Continuous Glucose Sensors in People with Diabetes Undergoing Hemodialysis (ALPHA Study)","volume":"25","author":"Avari","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"2026071311511106500_B16","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2337\/dc22-2348","article-title":"Evaluation of a fourth-generation subcutaneous real-time continuous glucose monitor (CGM) in individuals with diabetes on peritoneal dialysis","volume":"46","author":"Ng","year":"2023","journal-title":"Diabetes Care"},{"key":"2026071311511106500_B17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12882-024-03763-z","article-title":"Efficacy of continuous glucose monitoring in people living with diabetes and end stage kidney disease on dialysis: a systematic review","volume":"25","author":"Zhang","year":"2024","journal-title":"BMC Nephrol"},{"key":"2026071311511106500_B18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"key":"2026071311511106500_B19","volume-title":"VIReC Research User Guide: VHA Pharmacy Prescription Data.","author":"U.S. Department of Veterans Affairs, Health Services Research and Development Service, VA Information Resource Center."},{"key":"2026071311511106500_B20","volume-title":"VIReC Research User Guide: VHA Medical SAS Inpatient Datasets.","author":"U.S. Department of Veterans Affairs, Health Services Research and Development Service, VA Information Resource Center."},{"key":"2026071311511106500_B21","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/gerona\/gly232","article-title":"The burden of frailty among U.S. veterans and its association with mortality, 2002-2012","volume":"74","author":"Orkaby","year":"2019","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026071311511106500_B22","unstructured":"U.S. Department of Veterans Affairs, Health Services Research and Development Service, VA Information Resource Center.\n          VIReC Resource Guide: VA Corporate Data Warehouse.\n          Hines, IL: U.S. Department of Veterans Affairs, VA Information Resource Center, 2012"},{"key":"2026071311511106500_B23","unstructured":"U.S. Department of Veterans Affairs, Health Services Research and Development Service, VA Information Resource Center.\n          \n          VIReC Research User Guide: VHA Decision Support System Clinical National Data Extracts.\n          Hines, IL: US Department of Veterans Affairs, 2009"},{"key":"2026071311511106500_B24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/0962280214543508","article-title":"Double propensity-score adjustment: a solution to design bias or bias due to incomplete matching","volume":"26","author":"Austin","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"2026071311511106500_B25","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.diabres.2015.01.026","article-title":"Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: the DIALYDIAB pilot study","volume":"107","author":"Joubert","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"2026071311511106500_B26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5414\/CN108280","article-title":"Continuous glucose monitoring in hemodialyzed patients with type 2 diabetes: a multicenter pilot study","volume":"82","author":"K\u00e9p\u00e9n\u00e9kian","year":"2014","journal-title":"Clin Nephrol"},{"key":"2026071311511106500_B27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.34067\/KID.0000000000000396","article-title":"Continuous glucose monitoring and reduced diabetes-related hospitalizations in patients with type 2 diabetes and CKD","volume":"5","author":"Hannah","year":"2024","journal-title":"Kidney360"},{"key":"2026071311511106500_B28","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2026071311511106500_B29","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s00125-025-06388-5","article-title":"Cardiac arrhythmia and hypoglycaemia among individuals with and without diabetes receiving haemodialysis (the CADDY study): a Danish multicentre cohort study","volume":"68","author":"Kofod","year":"2025","journal-title":"Diabetologia"},{"key":"2026071311511106500_B30","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3390\/antiox10081306","article-title":"Pathophysiological association between diabetes mellitus and endothelial dysfunction","volume":"10","author":"Maruhashi","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"2026071311511106500_B31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","article-title":"Diabetic vascular diseases: molecular mechanisms and therapeutic strategies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026071311511106500_B32","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2337\/dc18-0287","article-title":"Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study","volume":"41","author":"Critchley","year":"2018","journal-title":"Diabetes Care"},{"key":"2026071311511106500_B33","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1592\/phco.2005.25.7.963","article-title":"Relationship between hyperglycemia and infection in critically ill patients","volume":"25","author":"Butler","year":"2005","journal-title":"Pharmacotherapy"},{"key":"2026071311511106500_B34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.amjms.2015.11.011","article-title":"The effect of short-term hyperglycemia on the innate immune system","volume":"351","author":"Jafar","year":"2016","journal-title":"Am J Med Sci"},{"key":"2026071311511106500_B35","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2337\/dc20-0316","article-title":"Severe hypoglycemia and risk of falls in type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"43","author":"Lee","year":"2020","journal-title":"Diabetes Care"},{"key":"2026071311511106500_B36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/STROKEAHA.124.049178","article-title":"Hypoglycemic events may trigger acute ischemic stroke within 30 days in those with diabetes: a case-crossover study","volume":"56","author":"Makam","year":"2025","journal-title":"Stroke"},{"key":"2026071311511106500_B37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2215\/CJN.0000000826","article-title":"Barriers and opportunities in access to peritoneal dialysis across Veterans Health Administration","volume":"21","author":"Wadhwa","year":"2026","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026071311511106500_B38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jcjd.2025.10.174","article-title":"The effects of continuous glucose monitoring on patient-reported outcomes in adults with non-insulin-dependent type 2 diabetes: a randomized controlled trial","volume":"50","author":"Olu-Jordan","year":"2026","journal-title":"Can J Diabetes"},{"key":"2026071311511106500_B39","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/clinem\/dgae379","article-title":"Novel detection and progression markers for diabetes based on continuous glucose monitoring data dynamics","volume":"110","author":"Montaser","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026071311511106500_B40","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1089\/dia.2024.0496","article-title":"Enhancing type 1 diabetes immunological risk prediction with continuous glucose monitoring and genetic profiling","volume":"27","author":"Montaser","year":"2025","journal-title":"Diabetes Technol Ther"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/7\/1285\/881237\/dc260004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/7\/1285\/881237\/dc260004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:51:25Z","timestamp":1783957885000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/49\/7\/1285\/169526\/Continuous-Glucose-Monitoring-and-Mortality-Risk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,6,1]]},"published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc26-0004","relation":{"has-preprint":[{"id-type":"doi","id":"10.2337\/figshare.32125489","asserted-by":"object"},{"id-type":"doi","id":"10.2337\/figshare.32125489.v1","asserted-by":"object"}]},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}